Pediatric cancer recurrence is a significant concern for families navigating the challenges of childhood cancer diagnosis and treatment.Recent advancements in AI in medicine have shown promise in improving cancer risk prediction, particularly for conditions like gliomas, a common type of brain tumor in young patients.